How to Develop a Practical (and Compliant) Vendor Qualification Program - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

KeywordLocation
About Search
How to Develop a Practical (and Compliant) Vendor Qualification Program
This article introduces the "Q.U.E.S.T." approach for vendor qualification, a practical and compliant methodology for pharmaceutical and biopharmaceutical companies to qualify vendors and hence make well-informed purchasing-related decisions.


Pharmaceutical Technology
Volume 33, Issue 10

One of the timeless principles of commerce is caveat emptor (Latin for, "let the buyer beware"). Under the principle of caveat emptor, the buyer takes the responsibility for the condition of the items or quality of the services that he or she purchases. Prior to the current consumer protection laws, buyers had no warranties for the goods or services that they purchased. Today, most states require goods to be of "merchantable or sellable quality." As this condition is often next to impossible to define and enforce, buyers are advised to embrace the principle of caveat emptor prior to "signing on the dotted line."

While being conscious of the products and services purchased is good practice for consumers and most businesses, it is a regulatory requirement for pharmaceutical and bio-pharmaceutical manufacturers. For these organizations, the decisions where to purchase raw materials, components, manufacturing and testing equipment, and even consulting services, need to be well informed (and documented). The results of making poor purchasing decisions can lead to situations that impact product quality, regulatory compliance, company profits, and even the reputation of the company.

Vendor qualification and quality systems

The qualification process is defined by the American Society for Quality Control (ASQC) as "the process of demonstrating whether an entity is capable of fulfilling the specified requirement." Vendor qualification is the process by which a vendor is evaluated to determine if it can provide the necessary goods or services to the standards that the purchasing company requires.

Before discussing the best approach to qualifying different types of vendors, it is important to first understand the concept of quality systems. Quality systems are defined as "the processes, organizational structure, procedures and resources that are used to control variables associated with producing a product of consistent quality and that meets predefined specifications." In simpler words, an organization's entire operation is a measure of a product s quality and not simply the testing of its finished product.

This article employs the theme that vendor qualification is not solely an auditing process but rather a quality system in itself for the pharmaceutical or biopharmaceutical organization.

In order to introduce the quality-systems approach to vendor qualification, consider the following simple analogy. Professional football organizations do not sign on prospective athletes purely by the athlete's stated bench press or 40-yard dash statistics (i.e., final test results). There are several factors that are taken into consideration. The team management first determines what specifications the team requires for the open position, including, but not limited to, what the team is willing and able to spend for the position to be filled.

Once these user requirements are defined, candidate athletes are identified. After identifying the top prospect (or prospects) on paper, a selection is made. However, the process is far from over at this point. The selected individual (or individuals) is then physically and mentally evaluated by team doctors to determine his readiness to play professional football for that specific team. Only after successful fulfillment of the team's specific financial, physical, and mental requirements is the player contracted. However, as many are aware, this one-time assessment does not guarantee consistent performance throughout the player's contract. Therefore, the athlete's performance is regularly assessed to ensure continued ability to meets the needs of the team. If the professional cannot meet the team's current requirements, the he is subjected to performance improvement training and risks being traded or released.

Similar to the professional football candidate, a potential vendor should be thoroughly assessed against a company's requirements, compared to other candidate vendors, physically evaluated once selected (and before a contract is signed), and reevaluated as required and as defined on a regular basis. This article presents the Q.U.E.S.T. approach as a simple, effective, and compliant approach to vendor qualification.


ADVERTISEMENT

post a comment
Your email address will NOT be published.
appears with your comment
read our privacy policy
Note: does not support HTML
All comments submitted are subject to review, and may be delayed before posting. We reserve the right not to post comments.
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What factor do you think will be most significant in 2010 for determining the health of the market for contract manufacturing of active pharmaceutical ingredients?
The global economic recovery
The US economic recovery
Improved credit and financing flow to the small to emerging pharma/bio sector
Less restrictive inventory control by pharmaceutical companies
The level of competition from contract manufacturers in emerging markets
The global economic recovery
40%
The US economic recovery
13%
Improved credit and financing flow to the small to emerging pharma/bio sector
15%
Less restrictive inventory control by pharmaceutical companies
8%
The level of competition from contract manufacturers in emerging markets
23%
View Results
Eric LangerOutsourcing OutlookEric Langer A Bio View of Outsourcing
Patricia Van ArnumIngredients InsiderPatricia Van Arnum Advances in Custom Synthesis
Faiz kermaniSpotlightFaiz Kermani EU pricing dilemmas
Faiz kermaniStatistical Solutions Lynn Torbeck%RSD: Friend or Foe?
NSF, Microsoft Team in Cloud Computing
Keep an eye on that cargo
Pharma packs a punch
Another Boost for Vaccines
Rodney Dangerfield and R&D
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here